RU2010123021A - METHOD FOR DIAGNOSTIC OF BREAST CANCER BY RNA LEVEL OF IL-8 AND / OR IL-18 INTERLEUKIN RNA IN BLOOD PLASMA - Google Patents

METHOD FOR DIAGNOSTIC OF BREAST CANCER BY RNA LEVEL OF IL-8 AND / OR IL-18 INTERLEUKIN RNA IN BLOOD PLASMA Download PDF

Info

Publication number
RU2010123021A
RU2010123021A RU2010123021/15A RU2010123021A RU2010123021A RU 2010123021 A RU2010123021 A RU 2010123021A RU 2010123021/15 A RU2010123021/15 A RU 2010123021/15A RU 2010123021 A RU2010123021 A RU 2010123021A RU 2010123021 A RU2010123021 A RU 2010123021A
Authority
RU
Russia
Prior art keywords
rna
breast cancer
blood plasma
level
interleukin
Prior art date
Application number
RU2010123021/15A
Other languages
Russian (ru)
Other versions
RU2451937C2 (en
Inventor
Денис Владимирович Ребриков (RU)
Денис Владимирович Ребриков
Original Assignee
Закрытое акционерное общество "Научно-производственная фирма ДНК-Технология" (RU)
Закрытое акционерное общество "Научно-производственная фирма ДНК-Технология"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Закрытое акционерное общество "Научно-производственная фирма ДНК-Технология" (RU), Закрытое акционерное общество "Научно-производственная фирма ДНК-Технология" filed Critical Закрытое акционерное общество "Научно-производственная фирма ДНК-Технология" (RU)
Priority to RU2010123021/15A priority Critical patent/RU2451937C2/en
Publication of RU2010123021A publication Critical patent/RU2010123021A/en
Application granted granted Critical
Publication of RU2451937C2 publication Critical patent/RU2451937C2/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Способ диагностики рака молочной железы, основанный на измерении в плазме крови уровня РНК генов интерлейкинов IL-8 и/или IL-18 и сравнении уровня представленности РНК IL-8 и/или IL-18 с уровнем представленности РНК референсных генов. A method for diagnosing breast cancer based on measuring plasma levels of RNA of IL-8 and / or IL-18 interleukin genes in a blood plasma and comparing the level of IL-8 and / or IL-18 RNA representation with the level of RNA representation of reference genes.

Claims (1)

Способ диагностики рака молочной железы, основанный на измерении в плазме крови уровня РНК генов интерлейкинов IL-8 и/или IL-18 и сравнении уровня представленности РНК IL-8 и/или IL-18 с уровнем представленности РНК референсных генов. A method for diagnosing breast cancer based on measuring plasma levels of RNA of IL-8 and / or IL-18 interleukin genes in a blood plasma and comparing the level of IL-8 and / or IL-18 RNA representation with the level of RNA representation of reference genes.
RU2010123021/15A 2010-06-07 2010-06-07 Diagnostic technique for breast cancer by blood plasma interleukin il-8 and/or il-18 rna level RU2451937C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2010123021/15A RU2451937C2 (en) 2010-06-07 2010-06-07 Diagnostic technique for breast cancer by blood plasma interleukin il-8 and/or il-18 rna level

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2010123021/15A RU2451937C2 (en) 2010-06-07 2010-06-07 Diagnostic technique for breast cancer by blood plasma interleukin il-8 and/or il-18 rna level

Publications (2)

Publication Number Publication Date
RU2010123021A true RU2010123021A (en) 2011-12-20
RU2451937C2 RU2451937C2 (en) 2012-05-27

Family

ID=45403668

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010123021/15A RU2451937C2 (en) 2010-06-07 2010-06-07 Diagnostic technique for breast cancer by blood plasma interleukin il-8 and/or il-18 rna level

Country Status (1)

Country Link
RU (1) RU2451937C2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2742209C9 (en) * 2019-12-30 2021-06-24 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации METHOD FOR DIAGNOSING BREAST CANCER BY LEVEL OF MRNA TGFβ AND TNFα IN BLOOD PLASMA
RU2745424C1 (en) * 2020-09-04 2021-03-25 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации Method for diagnosing breast cancer and ovarian cancer by mmp-9 mrna level in blood plasma
RU2752971C1 (en) * 2020-09-18 2021-08-11 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации Method for diagnosing breast cancer by level of expression of il-10 and/or il-17 mrna in blood plasma

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2340896C1 (en) * 2007-05-17 2008-12-10 Негосударственное научно-исследовательское учреждение "Биомедицинский центр" Method of diagnostics of oncologic diseases

Also Published As

Publication number Publication date
RU2451937C2 (en) 2012-05-27

Similar Documents

Publication Publication Date Title
MX2013002084A (en) Biomarkers and methods of treatment.
EP3236262A3 (en) Surrogate functional diagnostics test for cancer
GB201300533D0 (en) Methods of monitoring conditions by sequence analysis
WO2011095623A3 (en) miRNA IN THE DIAGNOSIS OF OVARIAN CANCER
EP2576837A4 (en) Prostate cancer associated circulating nucleic acid biomarkers
NZ607282A (en) Method for using gene expression to determine prognosis of prostate cancer
EP4303584A3 (en) Methods for detecting signatures of disease or conditions in bodily fluids
EP4219765A3 (en) Prostate cancer prognosis using biomarkers
WO2009085234A3 (en) Use of micro-rna as a biomarker of immunomodulatory drug activity
TN2013000464A1 (en) Biomarkers for hedgehog inhibitor therapy
EP2611941A4 (en) Gene signatures for cancer diagnosis and prognosis
MX2013000502A (en) Methods and kits for the diagnosis of prostate cancer.
EA201590773A1 (en) METHOD OF DIAGNOSTICS FOR PREDICTING THE RESPONSE TO THE INHIBITOR OF THE ALPHA (TNF ALPHA) TUMOR NECROSIS FACTOR
WO2012109466A3 (en) Long non-coding rna spry4-it1 as a diagnostic and therapeutic agent
EA201591742A1 (en) METHOD FOR IMPROVING DIAGNOSTIC DISEASES USING MEASURED ANALYTES
WO2014078468A3 (en) Biomarkers for predicting clinical response of cancer patients to treatment with immunotherapeutic agent
WO2015081283A3 (en) Long non-coding rna as a diagnostic and therapeutic agent
ES2570631T3 (en) Apolipoprotein AII determination procedure for in vitro diagnosis of colorectal cancer
EP3385717A3 (en) Methods of detecting prostate cancer
RU2010123021A (en) METHOD FOR DIAGNOSTIC OF BREAST CANCER BY RNA LEVEL OF IL-8 AND / OR IL-18 INTERLEUKIN RNA IN BLOOD PLASMA
AU2012371260A8 (en) Predicitive biomarker for cancer treatment with ADCC enhanced antibodies
WO2013033459A3 (en) Compositions, methods and uses for peptides in diagnosis, progression and treatment of cancers
EP3153861A3 (en) Biomarkers for predicting response to a cancer vaccine
BR112014028659A2 (en) cancer diagnostic methods, erlotinib, uses of an autoantibody, kits and invention
RU2013140122A (en) DIAGNOSTIC METHOD OF BREAST CANCER

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20140608